Bio–Rich Van Konynenburg 10-24-11

by | Dec 1, 2011

Bio for Rich Van Konynenburg:

Rich Van Konynenburg’s formal education was in engineering and the applied physical sciences. He received a Ph.D. degree from the University of California–Davis in 1974 as a Hertz Fellow. He served as an officer in the U.S. Army Corps of Engineers for two years, achieving the rank of Captain, doing research and development on detection of land mines and hidden explosives. He worked for the University of California at Lawrence Livermore National Laboratory for 30 years, doing research and development on nuclear materials and technology, associated primarily with nuclear fusion and nuclear waste management.

He has studied ME/CFS ( myalgic encephalomyelitis/chronic fatigue syndrome) for the past 15 years. In 2007, he proposed a hypothesis for the pathogenesis and pathophysiology of CFS/ME, called the “Glutathione Depletion—Methylation Cycle Block” hypothesis. The article in this issue reports on a clinical study with Neil Nathan, M.D., of a treatment based on this hypothesis.

Resume:

Richard A. Van Konynenburg

Education:

B.S. with honors, University of California, Davis, 1963, Engineering

M.S., University of California, Davis, 1965, Engineering—Applied Science

Ph.D. University of California, Davis, 1974, Engineering—Applied Science

Hertz Foundation Fellowship

Advertisement

Employment:

U.S. Army, Corps of Engineers, Officer and Research and Development

Coordinator, 1968-1970, temporary duty in Vietnam, honorable discharge.

University of California Lawrence Livermore National Laboratory, Chemistry and Materials Science Directorate, student employee, 1970-1974; scientific staff member 1974-2002.

University of California, Davis, lecturer in solid state physics, Applied Science Department, 1988-1990

U.S. Environmental Protection Agency, Consultant to Scientific Advisory Board Subcommittee on Carbon-14 Release, 1992-93.

Independent researcher of chronic fatigue syndrome, 1996 to present

Independent consultant on chronic fatigue syndrome, 2006 to present

Publications and lectures on chronic fatigue syndrome:

Van Konynenburg, R.A., Nutritional approaches, Chapter 27 in Handbook of Chronic Fatigue Syndrome, L.A. Jason et al., eds., John Wiley and Sons, Hoboken, NJ (2003).

Van Konynenburg, R.A., Is glutathione depletion an important part of the pathogenesis of chronic fatigue syndrome? poster paper, 7th Scientific Conference of the American Association for Chronic Fatigue Syndrome, Madison, Wisconsin (2004).

Van Konynenburg, R.A., Chronic fatigue syndrome and autism, Townsend Letter for Doctors and Patients (October 2006).

Van Konynenburg, R.A., Glutathione depletion—methylation cycle block, a hypothesis for the pathogenesis of chronic fatigue syndrome, poster paper, 8th International Conference of the International Association for Chronic Fatigue Syndrome (IACFS), Ft. Lauderdale, Florida (2007).

Van Konynenburg, R.A., Why is the prevalence of chronic fatigue syndrome higher in women than in men? poster paper, 8th International Conference of the IACFS, Ft. Lauderdale, Florida (2007).

Van Konynenburg, R.A., Methylation and glutathione, keys to chronic fatigue syndrome, invited lecture, Orthomolecular Health Medicine Society meeting, San Francisco (February 29, 2008), CD 09-108, No. 4, available from Professional Audio Recording, La Verne, CA, phone 1-800-430-4727, email PAR4AUDIO@aol.com.

Van Konynenburg, R.A., The glutathione depletion—methylation cycle block hypothesis for CFS/ME and implications for treatment, the IACFS/ME Bulletin (Summer, 2008).

Nathan, N. and Van Konynenburg, R.A., Treatment study of methylation cycle

support in patients with chronic fatigue syndrome and fibromyalgia, poster

paper, 9th International Conference of the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (IACFS/ME), Reno, Nevada (2009).

Van Konynenburg, R.A., Is there a link between Lyme disease and chronic

fatigue syndrome?, poster paper, 9th International Conference of the IACFS/ME,

Reno, Nevada (2009).

Van Konynenburg, R.A., and Nathan, N., Application of the Yasko protocol to the treatment of chronic fatigue syndrome, invited lecture, Yasko Protocol Conference, Boston (July 30-August 1, 2010).

Van Konynenburg, R.A., A comprehensive biochemical model for

the pathogenesis and pathophysiology of ME/CFS and effective treatment based

on it, poster paper, 10th International Biennial Conference of the IACFS/ME, Ottawa (September 22-25, 2011).

Van Konynenburg, R.A., Myalgic encephalomyelitis/chronic fatigue syndrome, invited seminar, Annual Meeting of the Swedish Chapter of the International Academy of Oral Medicine and Toxicology, Skovde, Sweden, October 1-2, 2011.

Author

Already Subscribed?

Search

Formatting updates are ongoing for older articles.

Author

Featured Articles

Where are your Clinical Trials?

It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized. 

A Renewed Focus on Self-Help for Healing

As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...

Issue Archives

Event Calendar

  • Integrative Cancer Symposium 2026 – Believe BIG

    Sheraton, Towson MD Towson, MD, United States

    Optimize Your Health. Transform Your Future. Join us for this dynamic one-day experience designed for anyone seeking to take a proactive, whole-body approach to health. Integrative oncology is a dynamic and rapidly evolving field, unveiling groundbreaking discoveries and new possibilities every day. This year’s one-day conference will take place at the Sheraton in Towson, Maryland from 9am – 5pm and offers both in-person and virtual attendance options. This event brings together leading experts in integrative oncology, functional medicine, and wellness. Discover cutting-edge approaches to prevention, treatment, recovery, and whole-person wellness at the Integrative Cancer Symposium Believe Big 2026. Learn from leading clinicians, researchers, and innovators in integrative oncology as they explore emerging therapies, metabolic and lifestyle approaches, mistletoe therapy, nutrition, environmental health, mindset, and more. Whether you are navigating cancer personally, supporting a loved one, or simply looking to optimize your health and reduce future risk, this powerful one-day experience offers practical tools, fresh insights, and meaningful connection.

  • PLMI 14th Annual Thought Leaders Consortium

    Loews Coronado Bay Resort 4000 Coronado Bay Rd, Coronado, CA, United States

    The 14th Annual Thought Leaders Consortium marks the culminating chapter of PLMI’s three-year exploration into the biology of immuno-metabolism, epigenetic regulation, and human longevity. Building on the 2024 and 2025 Consortia—which reframed chronic disease through immune-metabolic dysfunction and diet- and environment-driven epigenetic remodeling—this year’s gathering places mitochondria at the center of health, disease, and aging. Once viewed simply as the cell’s energy producers, mitochondria are now recognized as dynamic, epigenetically responsive organelles that integrate nutrition, environmental exposures, immune activation, stress signaling, physical activity, and circadian inputs into a unified metabolic-immune system. Disruption of mitochondrial function is increasingly implicated in fatigue syndromes, chronic pain, immune dysregulation, neurodegeneration, infertility, metabolic disease, accelerated aging, and diminished stress resilience. This advanced, science-driven Consortium convenes world-leading experts to explore mitochondrial biology as the cornerstone of immuno-metabolic resilience. Attendees will gain cutting-edge insights into mitochondrial signaling, mito-nuclear communication, and metabolic flexibility—alongside clinically actionable frameworks for restoring cellular vitality, reversing biological aging trajectories, and extending healthspan. Through deep scientific exploration and translational clinical strategy, the 2026 Thought Leaders Consortium will equip practitioners and researchers with the knowledge needed to redefine assessment, intervention, and long-term outcomes in personalized and lifestyle medicine.

    $650
  • Practical Clinical Skills in Neurotransmitter Optimization: Clinical Herbalism for Mood, Cognition & Aging

    Virtual Event

    Join us for the second part of this two-part virtual symposium! Mental health and neurocognitive disorders remain among the most prevalent and inadequately addressed challenges in modern clinical practice.  This intensive, expert-led symposium provides a comprehensive, clinically grounded framework for integrating herbal and nutraceutical strategies into mental health care. Attendees gain a working understanding of how targeted herbal interventions modulate key neurotransmitter systems, including serotonin, dopamine, GABA, and cortisol, and how to apply these therapies strategically, whether as adjuncts to pharmaceuticals or as standalone options. Clinical applications span a wide spectrum, from anxiety and depression to Parkinson’s-related motor symptoms and age-associated cognitive decline, with a strong emphasis on practical implementation and patient-specific protocol design.

Related Posts

The GMO-to-Cancer Pathway

By Michelle Perro, MD – Early-onset colorectal cancer, generally defined as colorectal cancer diagnosed before age 50, has been rising for decades. The phenomenon is particularly disturbing because many cases occur in people without an obvious hereditary cancer syndrome.

Read More

0 Comments

Submit a Comment

Pin It on Pinterest

Share This